Table 2 CT quantified characteristics in all datasets
Characteristics | Training set (n = 999) | Validation set (n = 250) | test 1 (n = 173) | test 2 (n = 289) | test 3 (n = 124) |
|---|---|---|---|---|---|
Age, years, Median (IQR) | 56.0(23.0) | 55.0(23.0) | 57.0(25.0) | 56.0(20.0) | 63.0(12.0) |
Sex, male, n(%) | 439.0(43.9) | 103(.041.2) | 77.0(44.5) | 117.0(40.5) | 71.0(57.3) |
Total pancreatic volume, cm3, Median (IQR) | 80.5(68.6) | 80.7(65.9) | 79.2(56.7) | 70.4(36.7) | 57.5(32) |
Net pancreatic volume, cm3, Median (IQR) | 77.2(64.4) | 77.1(64.4) | 78.2(52.5) | 68.8(35.6) | 54.8(29.8) |
Maximum diameter of the MPD in the pancreatic head, mm, Median (IQR) | 4.0(5.5) | 4.0(5.1) | 4.0(3.8) | 2.8(2.5) | 2.0(2.0) |
Maximum diameter of the MPD in the pancreatic body, mm, Median (IQR) | 4.0(6) | 4.0(4.6) | 4.5(5.5) | 2.0(4.5) | 2.0(2.0) |
Maximum diameter of the MPD in the pancreatic tail, mm, Median (IQR) | 2.0(4.9) | 2.0(4.5) | 2.8(4.9) | 2.0(2.8) | 2.0(2.0) |
The number of patients with tumors in the pancreatic head, n(%) | 432.0(43.2) | 104.0(41.6) | 69(39.9) | 111(38.4) | 70.0(56.5) |
Maximum diameter of the tumor, mm, Median (IQR) | 33.4(27.6) | 32.1(27) | 32.0(26.7) | 33.4(30.9) | 28.9(19.9) |
The average attenuation of solid tumor component in arterial phase on the largest tumor cross-section, HU, Median (IQR) | 53.6(14.9) | 53.3(14.7) | 52.0(14.5) | 50.0(12.9) | 49.3(11.9) |
The average attenuation of solid tumor component in portal phase on the largest tumor cross-section, HU, Median (IQR) | 59.3(20.5) | 58.3(18.7) | 59.4(19.3) | 57.2(23.8) | 50.2(17.9) |
Solid component volume of the tumor, mm3, Median (IQR) | 4093.2(12314.5) | 3397.2(9528.4) | 3270.1(9891.8) | 4663.6(12682.4) | 2404.1(6428.3) |
Solid component volume ratio, n(%) | 0.5(0.5) | 0.5(0.5) | 0.5(0.4) | 0.4(0.5) | 0.3(0.4) |
The maximum attenuation of solid tumor component volume in portal phase, HU, Median (IQR) | 60.1(19.8) | 59.9(18.4) | 60.2(17.9) | 59.2(23.2) | 52.8(16.9) |